We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Olympus Licenses Digital Pathology Patents to Leica Microsystems

By LabMedica International staff writers
Posted on 05 Apr 2011
Olympus America Inc.(Center Valley, PA, USA) and Leica Microsystems GmbH (Wetzlar, Germany) entered into a nonexclusive worldwide licensing agreement allowing Leica to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. More...
The companies did not make specific terms and conditions of the agreement public.

The patents included in the licensing deal cover methods and equipment for creating, storing, and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

Olympus America Scientific Equipment Group provides microscope-imaging solutions for clinicians, researchers, doctors, and educators. The company is a precision technology leader, designing and delivering innovative solutions in its core business areas: medical and surgical products, life science imaging systems, industrial measurement, and imaging instruments, and cameras and audio products.

Leica Microsystems GmbH is a global manufacturer of optical microscopes, equipment for the preparation of microscopic specimens, and related products. Stefan Traeger, managing director of Leica's Life Science Division commented, "We believe digital slide scanning will be the fastest growing segment in microscopy for years to come. This license agreement will enable us to further expand our offering in this space, and to provide our customers around the world with a complete solution from digital scanning of microscopy slides to the handling and management of digital pathology data."

Related Links:

Olympus America Inc.
Leica Microsystems GmbH



New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.